SALL4 Total Assay Kit Human and Mouse

The AlphaLISA™ SureFire® Ultra™ assay enables the rapid and sensitive detection of total and phosphorylated cellular proteins. AlphaLISA™ assays utilize two bead types: Acceptor Beads and Donor Beads. The Acceptor Bead is coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody which is labeled with a CaptSure™ tag. The Donor Bead is coated with streptavidin to capture the biotinylated antibody.  

In the presence of a target protein, the two target-specific antibodies bring Donor and Acceptor Beads into close proximity. When the Donor Beads are activated by a laser (680 nm), singlet oxygen is transferred to the Acceptor Bead leading to the production of an Alpha signal. The amount of light emission (615 nm) from the Acceptor Bead is directly proportional to the amount of target protein present in the sample. If an Acceptor Bead is not in close proximity (i.e. 200 nm) of a Donor bead, little to no signal is produced over background. 

The assay can be executed in a 1-plate or 2-plate assay protocol (Refer to Manual for more details).  

1-plate assay protocol: culturing of cells, treatment, lysis and assay are performed in a single well, enabling miniaturization in high throughput screening programs. 

2-plate assay protocol: cells are cultured and treated in a 96-well culture plate and lysates are then transferred into a separate plate for assay. This format allows the evaluation of multiple targets from a single lysate. 

Data obtained with a 2-plate, 2-incubation protocol. BeWo cells were seeded at 40K cells/well in 10% FBS containing medium and incubated overnight. Cells were treated with NVP-DKY709 at the indicated concentrations for 24 hours. Cells were washed and lysed with Lysis Buffer, further diluted and assayed separately for Total SALL4 and Total Cofilin using respective SureFire® Ultra™ kits. Equivalent to approximately 2,000 cells/datapoint for Total SALL4 and 200 cells for Total Cofilin.

Data obtained with a 2-plate, 2-incubation protocol. BeWo cells were seeded at 20K cells/well in 10% FBS containing medium and incubated overnight. Cells were treated with Thalidomide at the indicated concentrations for 24 hours. Cells were washed and lysed with Lysis Buffer, further diluted and assayed separately for Total SALL4 and Total Cofilin using respective SureFire® Ultra™ kits. Equivalent to approximately 1,000 cells/datapoint for Total SALL4 and 100 cells for Total Cofilin.

Data obtained from measurement of SALL4 Total in various cell types lysed with Lysis Buffer. Equivalent to approximately 4,000 cells/datapoint (adherent cells) or 40,000 cells/datapoint (suspension cells).